Research programme: selective androgen receptor modulator - PfizerAlternative Names: CE-590; SARMs - Pfizer
Latest Information Update: 04 Aug 2009
At a glance
- Originator Pfizer
- Mechanism of Action Selective androgen receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Male osteoporosis
Most Recent Events
- 04 Aug 2009 No development reported (preclinical) for Male osteoporosis in USA (PO)
- 22 Jun 2005 Preclinical trials in Male osteoporosis in USA (PO)